专业监测看板

Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels

药物 / 成分：Standard of Care Chemotherapy、Video-Assisted Thoracic Surgery (VATS)、Lobectomy、Consolidative Radiation

登记的停止原因（原文）：PI left site

A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms

药物 / 成分：Ivosidenib、Enasidenib、Fedratinib

登记的停止原因（原文）：unable to accrue

Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.

药物 / 成分：Human albumin、Saline solution

登记的停止原因（原文）：Internal reorganisations and lack of funding by the sponsor

Pharmacological vs Surgical Treatment for Mixed Incontinence

药物 / 成分：Tolterodine、tension free vaginal tape

登记的停止原因（原文）：it stopped at a regulatory stage

Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS

药物 / 成分：Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles、Saline

登记的停止原因（原文）：Change in development plan

Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years

药物 / 成分：Sancuso、IV granisetron

登记的停止原因（原文）：The company currently does not have plans to conduct this study

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

药物 / 成分：Sancuso、IV granisetron

登记的停止原因（原文）：The company currently does not have plans to conduct this study

Caudal vs. Pudendal Block in Peds GU

药物 / 成分：Caudal Block、Ultrasound-guided Pudendal Block、Injectable 1 ml/kg of 0.25% ropivacaine with 1mcg/kg dexmedetomidine、Injection of 0.5 ml/kg per side of injectable 0.2-0.3% ropivacaine with 0.5 mcg/kg dexmetomedine.

登记的停止原因（原文）：PI leaving institution

Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)

药物 / 成分：cemiplimab、fianlimab

登记的停止原因（原文）：Business Decision

Psilocybin for Major Depressive Disorder

药物 / 成分：Psilocybin

登记的停止原因（原文）：Resident who was tasked with coordinating this study is no longer able to do so.

Cardiovascular Risk Reduction in Epilepsy

药物 / 成分：Neurologist Initiated Treatment、Placebo

登记的停止原因（原文）：not funded

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer

药物 / 成分：Biospecimen Collection、Carboplatin、Chest Radiography、Cisplatin

登记的停止原因（原文）：A phase III trial of the investigational agent failed to pass futility boundaries at interim analysis

Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray

药物 / 成分：Dupilumab

登记的停止原因（原文）：Closed by sponsor, lack of enrollment.

Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma

药物 / 成分：Tebentafusp (IMCgp100)

Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI

药物 / 成分：19F Cell Sense-labeled PBMC、MRI

登记的停止原因（原文）：Lack of funding

Use of Tranexamic Acid in Blepharoplasties

药物 / 成分：Tranexamic acid injection

登记的停止原因（原文）：Stopped study due to pharmacy issues before treating patients

Chinese Herbal Medicine for Gynecologic Patients

药物 / 成分：Chinese Herbal Medicine (CHM) supplement、Placebo

登记的停止原因（原文）：Study withdrawn due to inability to determine path forward regarding study design between sponsor and institutional staff.

Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL

药物 / 成分：allogeneic CAR19 regulatory T cells (CAR19-tTreg)、Fludarabine、Cyclophosphamide

登记的停止原因（原文）：replaced with a new IND and protocol

Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis

药物 / 成分：Apraclonidine

登记的停止原因（原文）：The project never opened.

Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma

药物 / 成分：Onvansertib、Gemcitabine、Nab-paclitaxel、Electrocardiography

登记的停止原因（原文）：Sponsor withdrawal